You are here

  • Home
  • Archive
  • Volume 7, Issue Suppl 1
  • 154: A PHARMACOECONOMIC EVALUATION TO MAKE DECISION: IS THE USE OF SIMVASTATIN 10 MG AS AN OTC MEDICATION COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF STROKE AMONGST WOMEN IN IRAN?

Citation Tools

Article menu

Download PDFPDF

XML
Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Iran
Oral
154: A PHARMACOECONOMIC EVALUATION TO MAKE DECISION: IS THE USE OF SIMVASTATIN 10 MG AS AN OTC MEDICATION COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF STROKE AMONGST WOMEN IN IRAN?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Amirsadri M, Dorri N
154: A PHARMACOECONOMIC EVALUATION TO MAKE DECISION: IS THE USE OF SIMVASTATIN 10 MG AS AN OTC MEDICATION COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF STROKE AMONGST WOMEN IN IRAN?
BMJ Open 2017;7:bmjopen-2016-015415.154. doi: 10.1136/bmjopen-2016-015415.154